|
GB771147A
(en)
|
1954-06-04 |
1957-03-27 |
Merck & Co Inc |
Derivatives of urea
|
|
US3152136A
(en)
|
1958-10-30 |
1964-10-06 |
Dow Chemical Co |
Dinitroaroyl-nu-pyridyl amides
|
|
US3067250A
(en)
|
1959-01-26 |
1962-12-04 |
Dow Chemical Co |
4-aryl, 1, 1-di propynyl-semicarbazides
|
|
US3317534A
(en)
|
1963-10-30 |
1967-05-02 |
Chugai Pharmaceutical Co Ltd |
Benzamidopyrimidines
|
|
US3551442A
(en)
|
1965-04-06 |
1970-12-29 |
Pechiney Saint Gobain |
Thiazole derivatives
|
|
US3424762A
(en)
|
1966-03-07 |
1969-01-28 |
Robins Co Inc A H |
Certain 3-ureidopyrrolidines
|
|
ZA6706928B
(https=)
|
1967-03-23 |
|
|
|
|
CH493195A
(de)
|
1968-01-23 |
1970-07-15 |
Ciba Geigy |
Schädlingsbekämpfungsmittel
|
|
US4175081A
(en)
|
1968-02-01 |
1979-11-20 |
Mobil Oil Corporation |
5-Substituted thiadiazole ureas
|
|
GB1195672A
(en)
|
1968-02-01 |
1970-06-17 |
Mobil Oil Corp |
Novel Urea Derivatives and Herbicides containing the same
|
|
FR7428M
(https=)
|
1968-05-06 |
1969-11-12 |
|
|
|
CH498859A
(de)
|
1968-07-17 |
1970-11-15 |
Agripat Sa |
Verfahren zur Herstellung von Thiadiazolyl-harnstoffen
|
|
GB1266769A
(https=)
|
1969-08-15 |
1972-03-15 |
|
|
|
BE754783A
(fr)
|
1969-08-15 |
1971-02-12 |
May & Baker Ltd |
Derives thiazolyl a usage herbicide leur preparation et les compositions qui les contiennent
|
|
GB1318291A
(en)
|
1970-04-15 |
1973-05-23 |
Shell Int Research |
Carboxamide derivatives and fungicidal compositions containing them
|
|
NL7106557A
(https=)
|
1970-06-15 |
1971-12-17 |
|
|
|
IT960595B
(it)
|
1971-06-16 |
1973-11-30 |
Hispaco Ag |
Navetta per tessitura
|
|
US3887709A
(en)
|
1971-09-16 |
1975-06-03 |
Zdzislaw Brzozowski |
2-Pyrazoline-1-carboxamide sulfonamide derivatives useful as hypoglycemic agents
|
|
US3862163A
(en)
|
1971-10-14 |
1975-01-21 |
Schering Ag |
Phenoxycarboxylic acid amides
|
|
DE2151766C3
(de)
|
1971-10-14 |
1981-03-19 |
Schering Ag, 1000 Berlin Und 4619 Bergkamen |
N-Thiazolinyl-phenoxycarbonsäureamide
|
|
US3874873A
(en)
|
1972-03-27 |
1975-04-01 |
Fmc Corp |
Herbicidal compositions based on 1,2,3-thiadiazol-5-yl ureas
|
|
IL44058A
(en)
|
1973-02-02 |
1978-10-31 |
Ciba Geigy Ag |
3amino-1,2,4-benzotriazine 1,4-di-noxide derivatives, their preparation and compositions for the control of microorganisms containing them
|
|
AT323195B
(de)
|
1973-03-16 |
1975-06-25 |
Hurka Wilhelm |
Verfahren zur herstellung neuer salze von biguaniden
|
|
JPS5614643B2
(https=)
|
1973-07-02 |
1981-04-06 |
|
|
|
FR2243684B1
(https=)
|
1973-09-19 |
1977-01-28 |
Semb |
|
|
PL106114B1
(pl)
|
1976-12-31 |
1979-11-30 |
Akad Medyczna |
Sposob wytwarzania nowych n-(4-/2-/pirazolo-1-karbonamido/-etylo/-benzenosulfonylo)-mocznikow
|
|
DE2712630A1
(de)
|
1977-03-23 |
1978-09-28 |
Bayer Ag |
1,3,4-thiadiazol-2-yl-harnstoffe, verfahren zu ihrer herstellung sowie ihre verwendung als fungizide
|
|
DE2716324A1
(de)
|
1977-04-07 |
1978-10-12 |
Schering Ag |
1,2,3-thiadiazol-3-in-5-yliden- harnstoffe, verfahren zur herstellung dieser verbindungen sowie diese enthaltende mittel mit wachstumsregulatorischer wirkung fuer pflanzen
|
|
JPS6033109B2
(ja)
|
1977-04-28 |
1985-08-01 |
塩野義製薬株式会社 |
尿素誘導体の合成法
|
|
US4241072A
(en)
|
1979-01-18 |
1980-12-23 |
Merck & Co., Inc. |
Substituted ureas and processes for their preparation
|
|
DE2928485A1
(de)
|
1979-07-14 |
1981-01-29 |
Bayer Ag |
Verwendung von harnstoffderivaten als arzneimittel bei der behandlung von fettstoffwechselstoerungen
|
|
IL72093A0
(en)
|
1983-06-20 |
1984-10-31 |
Lilly Co Eli |
N'-substituted(3-alkyl-5-isothiazolyl)urea derivatives
|
|
US4694004A
(en)
|
1984-07-09 |
1987-09-15 |
Fujisawa Pharmaceutical Co., Ltd. |
Semicarbazide derivatives, processes for preparation thereof and pharmaceutical composition comprising the same
|
|
US4808722A
(en)
|
1985-10-31 |
1989-02-28 |
Fmc Corporation |
Pyridinylurea N-oxide compounds and agricultural uses
|
|
JPS6456660A
(en)
|
1987-05-11 |
1989-03-03 |
Sumitomo Chemical Co |
Urea derivative or its salt, production thereof and germicide for agriculture and horticulture containing said derivative or salt thereof as active ingredient
|
|
WO1991004027A1
(en)
|
1989-09-15 |
1991-04-04 |
Pfizer Inc. |
New n-aryl and n-heteroarylamide and urea derivatives as inhibitors of acyl coenzyme a: cholesterol acyl transferase (acat)
|
|
IE68593B1
(en)
|
1989-12-06 |
1996-06-26 |
Sanofi Sa |
Heterocyclic substituted acylaminothiazoles their preparation and pharmaceutical compositions containing them
|
|
US5552160A
(en)
|
1991-01-25 |
1996-09-03 |
Nanosystems L.L.C. |
Surface modified NSAID nanoparticles
|
|
US5145684A
(en)
|
1991-01-25 |
1992-09-08 |
Sterling Drug Inc. |
Surface modified drug nanoparticles
|
|
RU2021258C1
(ru)
|
1991-02-28 |
1994-10-15 |
Агролинц Агрархемикалиен ГмбХ |
Способ получения несимметрично дизамещенных мочевин
|
|
US5371086A
(en)
|
1991-03-15 |
1994-12-06 |
The Green Cross Corporation |
Aminopyridine compounds
|
|
JPH05294935A
(ja)
|
1991-03-15 |
1993-11-09 |
Green Cross Corp:The |
アミノピリジン系化合物
|
|
WO1993024458A1
(en)
|
1992-05-28 |
1993-12-09 |
Pfizer Inc. |
New n-aryl and n-heteroarylurea derivatives as inhibitors of acyl coenzyme a:cholesterol acyl transferase (acat)
|
|
WO1994014801A1
(en)
|
1992-12-29 |
1994-07-07 |
Smithkline Beecham Plc |
Heterocyclic urea derivatives as 5ht2c and 5ht2b antagonists
|
|
GB9302275D0
(en)
|
1993-02-05 |
1993-03-24 |
Smithkline Beecham Plc |
Novel compounds
|
|
US5849769A
(en)
|
1994-08-24 |
1998-12-15 |
Medivir Ab |
N-arylalkyl-N-heteroarylurea and guandine compounds and methods of treating HIV infection
|
|
US5556969A
(en)
|
1994-12-07 |
1996-09-17 |
Merck Sharp & Dohme Ltd. |
Benzodiazepine derivatives
|
|
US6579314B1
(en)
|
1995-03-10 |
2003-06-17 |
C.R. Bard, Inc. |
Covered stent with encapsulated ends
|
|
WO1996040629A1
(en)
|
1995-06-07 |
1996-12-19 |
Sugen, Inc. |
Tyrphostin-like compounds for the treatment of cell proliferative disorders or cell differentiation disorders
|
|
US5846990A
(en)
|
1995-07-24 |
1998-12-08 |
Bristol-Myers Squibb Co. |
Substituted biphenyl isoxazole sulfonamides
|
|
JPH09124620A
(ja)
|
1995-10-11 |
1997-05-13 |
Bristol Myers Squibb Co |
置換ビフェニルスルホンアミドエンドセリン拮抗剤
|
|
GB9526560D0
(en)
|
1995-12-27 |
1996-02-28 |
Bayer Ag |
Use of 2-Amino-Heterocycles
|
|
CA2197364A1
(en)
|
1996-02-15 |
1997-08-16 |
Toshikazu Suzuki |
Phenol compound and process for preparing the same
|
|
AU1735497A
(en)
|
1996-02-26 |
1997-09-10 |
Sumitomo Pharmaceuticals Company, Limited |
Sulfonylureidopyrazole derivatives
|
|
TW523506B
(en)
|
1996-12-18 |
2003-03-11 |
Ono Pharmaceutical Co |
Sulfonamide or carbamide derivatives and drugs containing the same as active ingredients
|
|
US5846985A
(en)
|
1997-03-05 |
1998-12-08 |
Bristol-Myers Squibb Co. |
Substituted biphenyl isoxazole sulfonamides
|
|
SE9702001D0
(sv)
|
1997-05-28 |
1997-05-28 |
Astra Pharma Prod |
Novel compounds
|
|
US6268384B1
(en)
|
1997-08-29 |
2001-07-31 |
Vertex Pharmaceuticals Incorporated |
Compounds possessing neuronal activity
|
|
US6225346B1
(en)
|
1997-10-24 |
2001-05-01 |
Sugen, Inc. |
Tyrphostin like compounds
|
|
NZ503491A
(en)
|
1997-11-10 |
2002-08-28 |
Bristol Myers Squibb Co |
2-substituted amino-1,3-benzothiazole derivatives useful as protein tyrosine kinase inhibitors
|
|
US6040321A
(en)
|
1997-11-12 |
2000-03-21 |
Bristol-Myers Squibb Company |
Aminothiazole inhibitors of cyclin dependent kinases
|
|
US6262096B1
(en)
|
1997-11-12 |
2001-07-17 |
Bristol-Myers Squibb Company |
Aminothiazole inhibitors of cyclin dependent kinases
|
|
ES2262248T3
(es)
|
1997-11-14 |
2006-11-16 |
Kowa Company. Ltd. |
Nuevos compuestos amida y medicamente que los contienen.
|
|
SK286213B6
(sk)
|
1997-12-22 |
2008-05-06 |
Bayer Corporation |
Substituované heterocyklické močoviny, farmaceutický prípravok ich obsahujúci a ich použitie
|
|
MXPA00006233A
(es)
|
1997-12-22 |
2002-09-18 |
Bayer Ag |
Inhibicion de la actividad de la cinasa p38 utilizando ureas heterociclicas sustituidas.
|
|
UA60365C2
(uk)
|
1998-06-04 |
2003-10-15 |
Пфайзер Продактс Інк. |
Похідні ізотіазолу, спосіб їх одержання, фармацевтична композиція та спосіб лікування гіперпроліферативного захворювання у ссавця
|
|
US6407124B1
(en)
|
1998-06-18 |
2002-06-18 |
Bristol-Myers Squibb Company |
Carbon substituted aminothiazole inhibitors of cyclin dependent kinases
|
|
GT199900147A
(es)
|
1998-09-17 |
1999-09-06 |
|
1, 2, 3, 4- tetrahidroquinolinas 2-sustituidas 4-amino sustituidas.
|
|
GB9823873D0
(en)
|
1998-10-30 |
1998-12-30 |
Pharmacia & Upjohn Spa |
2-ureido-thiazole derivatives,process for their preparation,and their use as antitumour agents
|
|
CN1332726A
(zh)
|
1998-11-02 |
2002-01-23 |
卫福有限公司 |
吡咯烷化合物及其药物用途
|
|
US6337338B1
(en)
|
1998-12-15 |
2002-01-08 |
Telik, Inc. |
Heteroaryl-aryl ureas as IGF-1 receptor antagonists
|
|
WO2000053591A1
(de)
|
1999-03-08 |
2000-09-14 |
Bayer Aktiengesellschaft |
Thiazolylharnstoff-derivate und ihre verwendung als antivirale mittel
|
|
US6794412B1
(en)
|
1999-03-11 |
2004-09-21 |
Bristol-Myers Squibb Pharma Company |
Treatment of thrombosis by combined use of a factor Xa inhibitor and aspirin
|
|
US6610846B1
(en)
|
1999-03-29 |
2003-08-26 |
Hoffman-La Roche Inc. |
Heteroaromatic glucokinase activators
|
|
SI1169312T1
(en)
|
1999-03-29 |
2005-02-28 |
F. Hoffmann-La Roche Ag |
Glucokinase activators
|
|
US7125875B2
(en)
|
1999-04-15 |
2006-10-24 |
Bristol-Myers Squibb Company |
Cyclic protein tyrosine kinase inhibitors
|
|
US6503949B1
(en)
|
1999-05-17 |
2003-01-07 |
Noro Nordisk A/S |
Glucagon antagonists/inverse agonists
|
|
USRE40876E1
(en)
|
1999-06-21 |
2009-08-18 |
Eli Lilly And Company |
Method for treating non-insulin dependent diabetes using thiazolidinediones with glucagonlike peptide-1 and agonists thereof
|
|
BR0012068A
(pt)
|
1999-06-30 |
2002-05-14 |
Daiichi Seiyaku Co |
Compostos inibidores de vla-4
|
|
US6114365A
(en)
|
1999-08-12 |
2000-09-05 |
Pharmacia & Upjohn S.P.A. |
Arylmethyl-carbonylamino-thiazole derivatives, process for their preparation, and their use as antitumor agents
|
|
US6294546B1
(en)
|
1999-08-30 |
2001-09-25 |
The Broad Of Trustees Of The Leland Stanford Junior University |
Uses of diterpenoid triepoxides as an anti-proliferative agent
|
|
EP1211246B1
(en)
|
1999-09-09 |
2004-02-25 |
Kumiai Chemical Industry Co., Ltd. |
Pyrimidine derivatives and herbicides containing the same
|
|
US6353111B1
(en)
|
1999-12-15 |
2002-03-05 |
Hoffmann-La Roche Inc. |
Trans olefinic glucokinase activators
|
|
JP2003521543A
(ja)
|
2000-02-07 |
2003-07-15 |
アボット ゲーエムベーハー ウント カンパニー カーゲー |
２−ベンゾチアゾリル尿素誘導体およびそのプロテインキナーゼ阻害剤としての使用
|
|
US6608038B2
(en)
|
2000-03-15 |
2003-08-19 |
Novartis Ag |
Methods and compositions for treatment of diabetes and related conditions via gene therapy
|
|
AU2001252270B2
(en)
|
2000-05-03 |
2005-12-15 |
F. Hoffmann-La Roche Ag |
Hydantoin-containing glucokinase activators
|
|
KR100502033B1
(ko)
|
2000-05-03 |
2005-07-25 |
에프. 호프만-라 로슈 아게 |
알키닐 페닐 헤테로방향족 글루코키나제 활성제
|
|
KR100519826B1
(ko)
|
2000-05-08 |
2005-10-06 |
에프. 호프만-라 로슈 아게 |
파라-아민 치환된 페닐아미드 글루코키나제 활성화제
|
|
AU778036B2
(en)
|
2000-05-08 |
2004-11-11 |
F. Hoffmann-La Roche Ag |
Substituted phenylacetamides and their use as glucokinase activators
|
|
JP2004501191A
(ja)
|
2000-06-28 |
2004-01-15 |
テバ ファーマシューティカル インダストリーズ リミティド |
カルベジロール
|
|
MXPA03000365A
(es)
|
2000-07-20 |
2003-05-27 |
Hoffmann La Roche |
Bencenacetamida substituida con alfa-acilo y alfa-heteroatomo como activadores de la glucocinasa.
|
|
US20020173507A1
(en)
|
2000-08-15 |
2002-11-21 |
Vincent Santora |
Urea compounds and methods of uses
|
|
US6645990B2
(en)
|
2000-08-15 |
2003-11-11 |
Amgen Inc. |
Thiazolyl urea compounds and methods of uses
|
|
WO2002046173A1
(en)
|
2000-12-06 |
2002-06-13 |
F. Hoffmann-La Roche Ag |
Fused heteroaromatic glucokinase activators
|
|
WO2002060898A1
(en)
|
2001-01-31 |
2002-08-08 |
Pfizer Products Inc. |
Thiazolyl-, oxazolyl-, pyrrolyl-, and imidazolyl-acid amide derivatives useful as inhibitors of pde4 isozymes
|
|
UA76977C2
(en)
|
2001-03-02 |
2006-10-16 |
Icos Corp |
Aryl- and heteroaryl substituted chk1 inhibitors and their use as radiosensitizers and chemosensitizers
|
|
EP1256578B1
(en)
|
2001-05-11 |
2006-01-11 |
Pfizer Products Inc. |
Thiazole derivatives and their use as cdk inhibitors
|
|
JP2004536845A
(ja)
|
2001-07-11 |
2004-12-09 |
ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド |
サイトカイン媒介疾患の治療方法
|
|
US6881746B2
(en)
|
2001-12-03 |
2005-04-19 |
Novo Nordick A/S |
Glucagon antagonists/inverse agonists
|
|
WO2003055482A1
(en)
|
2001-12-21 |
2003-07-10 |
Novo Nordisk A/S |
Amide derivatives as gk activators
|
|
EP1321463B1
(en)
|
2001-12-21 |
2007-08-08 |
Virochem Pharma Inc. |
Thiazole derivatives and their use for the treatment or prevention of Flavivirus infections
|
|
BR0312023A
(pt)
|
2002-06-27 |
2005-03-22 |
Novo Nordisk As |
Composto, composto ativador da glicose cinase, método para evitar a hipoglicemia, uso de um composto, e, composição farmacêutica
|
|
NZ541824A
(en)
|
2003-02-26 |
2010-04-30 |
Banyu Pharma Co Ltd |
Heteroarylcarbamoylbenzene derivatives as glucokinase activators
|
|
US7111188B2
(en)
|
2003-07-31 |
2006-09-19 |
International Business Machines Corporation |
Dynamically configurable fault tolerance in autonomic computing with multiple service points
|
|
TW200505894A
(en)
|
2003-08-08 |
2005-02-16 |
Yamanouchi Pharma Co Ltd |
Tetrahydro-2H-thiopyran-4-carboxamide derivative
|
|
US7029649B2
(en)
|
2003-08-26 |
2006-04-18 |
General Motors Corporation |
Combinations of hydrogen storage materials including amide/imide
|
|
AU2003269484A1
(en)
|
2003-09-11 |
2005-03-29 |
Biocon Limited |
Salt of atorvastatin with metformin
|
|
JP4834840B2
(ja)
|
2004-01-06 |
2011-12-14 |
ノヴォ ノルディスク アー／エス |
ヘテロアリール尿素およびグルコキナーゼ活性化剤としてのその使用
|
|
CN1922664A
(zh)
|
2004-02-26 |
2007-02-28 |
皇家飞利浦电子股份有限公司 |
用于电子书应用的多螺旋混合盘
|
|
JP4334374B2
(ja)
|
2004-03-05 |
2009-09-30 |
株式会社東芝 |
被ばく線量評価方法、被ばく線量評価システムおよび被ばく線量評価プログラム
|
|
KR20070002081A
(ko)
|
2004-04-02 |
2007-01-04 |
버텍스 파마슈티칼스 인코포레이티드 |
Ｒｏｃｋ 및 기타 단백질 키나아제의 억제제로서 유용한아자인돌
|
|
JP2008502658A
(ja)
*
|
2004-06-17 |
2008-01-31 |
ノボ ノルディスク アクティーゼルスカブ |
肝臓選択的グルコキナーゼ活性化因子の使用
|
|
CA2582567A1
(en)
|
2004-10-07 |
2006-04-13 |
Stem Cell Therapeutics Corp. |
Stimulation of proliferation of pluripotential stem cells through administration of pregnancy associated compounds
|
|
US20060246141A1
(en)
|
2005-04-12 |
2006-11-02 |
Elan Pharma International, Limited |
Nanoparticulate lipase inhibitor formulations
|
|
US20100028439A1
(en)
|
2005-05-23 |
2010-02-04 |
Elan Pharma International Limited |
Nanoparticulate stabilized anti-hypertensive compositions
|
|
ES2382815T3
(es)
|
2005-07-08 |
2012-06-13 |
Novo Nordisk A/S |
Dicicloalquilcarbamoil ureas como activadores de glucoquinasa
|
|
US7582769B2
(en)
|
2005-07-08 |
2009-09-01 |
Novo Nordisk A/S |
Dicycloalkyl urea glucokinase activators
|
|
US7884210B2
(en)
|
2005-07-14 |
2011-02-08 |
Novo Nordisk A/S |
Ureido-thiazole glucokinase activators
|
|
US8163779B2
(en)
|
2006-12-20 |
2012-04-24 |
Takeda San Diego, Inc. |
Glucokinase activators
|
|
WO2008084043A1
(en)
|
2007-01-09 |
2008-07-17 |
Novo Nordisk A/S |
Urea glucokinase activators
|
|
WO2008084044A1
(en)
|
2007-01-11 |
2008-07-17 |
Novo Nordisk A/S |
Urea glucokinase activators
|
|
JPWO2009054251A1
(ja)
|
2007-10-25 |
2011-03-03 |
三洋電機株式会社 |
発電装置
|
|
BRPI0912802A2
(pt)
|
2008-05-16 |
2015-10-13 |
Takeda San Diego Inc |
ativadores de glicoquinase
|
|
WO2009140824A1
(en)
|
2008-05-22 |
2009-11-26 |
Yuvad Technologies Co., Ltd. |
A system for identifying motion video/audio content
|
|
WO2010107610A1
(en)
|
2009-03-17 |
2010-09-23 |
Merck Sharp & Dohme Corp. |
Method for treatment of diabetes and related conditions with combination therapy and compositions containing such compounds
|
|
EP2419097B1
(en)
|
2009-04-16 |
2013-09-25 |
Taisho Pharmaceutical Co., Ltd. |
Pharmaceutical composition comprising (1s)-1,5-anhydro-1-[5-(4-ethoxybenzyl)-2-methoxy-4-methylphenyl]-1-thio-d-glucitol and metformin and uses thereof in the treatment of diabetes
|
|
WO2011025270A2
(ko)
|
2009-08-25 |
2011-03-03 |
한올바이오파마주식회사 |
메트포르민 카페익산염, 그의 제조방법, 그를 포함하는 약학조성물 및 그를 포함하는 복합제제
|
|
PT2576524T
(pt)
|
2010-05-26 |
2017-11-17 |
Vtv Therapeutics Llc |
Resumo
|
|
EP2392575A1
(en)
|
2010-06-04 |
2011-12-07 |
LEK Pharmaceuticals d.d. |
A novel synthetic approach to ß-aminobutyryl substituted compounds
|
|
HK1202458A1
(en)
*
|
2012-05-17 |
2015-10-02 |
Vtv治疗有限责任公司 |
Glucokinase activator compositions for the treatment of diabetes
|
|
JP6016621B2
(ja)
|
2012-12-26 |
2016-10-26 |
花王株式会社 |
清掃具のジョイント構造
|
|
CN105188676A
(zh)
|
2013-03-04 |
2015-12-23 |
Vtv治疗有限责任公司 |
包括葡糖激酶活化剂的固体组合物及其制备和使用方法
|
|
HK1213780A1
(zh)
|
2013-03-04 |
2016-07-15 |
Vtv治疗有限责任公司 |
穩定的葡萄糖激酶活化劑組合物
|
|
JP6102611B2
(ja)
|
2013-07-31 |
2017-03-29 |
セイコーエプソン株式会社 |
液体噴射装置及びワイピング方法
|
|
US10696424B2
(en)
|
2016-06-29 |
2020-06-30 |
Lockheed Martin Corporation |
Spacecraft structures incorporating graphene and operation thereof
|
|
RU2728824C1
(ru)
|
2016-12-15 |
2020-07-31 |
Хуа Медсин (Шанхай) Лтд. |
Препарат активатора глюкокиназы для перорального введения и способ его получения
|
|
CN112040945A
(zh)
|
2018-06-12 |
2020-12-04 |
Vtv治疗有限责任公司 |
葡萄糖激酶激活剂与胰岛素或胰岛素类似物组合的治疗用途
|
|
US12391658B2
(en)
|
2020-02-18 |
2025-08-19 |
Vtv Therapeutics Llc |
Sulfoxide and sulfone glucokinase activators and methods of use thereof
|
|
CN116056760A
(zh)
|
2020-06-08 |
2023-05-02 |
维特卫治疗有限责任公司 |
{2-[3-环己基-3-(反式-4-丙氧基-环己基)-脲基]-噻唑-5-基硫烷基}-乙酸的结晶形式及其用途
|
|
CA3181722A1
(en)
|
2020-06-08 |
2021-12-16 |
Jing TENG |
Salts or co-crystals of {2-[3-cyclohexyl-3-(trans-4-propoxy-cyclohexyl)-ureido]-thiazol-5-ylsulfanyl}-acetic acid and uses thereof
|